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HUEPER (1938) and Bonser (1943) established that carcinoma of the bladder
may be induced by feeding 2-naphthylamine to dogs over a protracted period.
In the more recent experiments of Bonser, Clayson, Jull and Pyrah (1952) the
oral administration of 2-naphthylamine to mice resulted in a significant yield of
liver tumours, but in 5 rabbits which survived 4 years of treatment the only
changes induced were a small papilloma of the bladder in one and advanced
epithelial hyperplasia in another. Bonser, Clayson and Jull (1951) presented
evidence that 2-naphthylamine is carcinogenic by virtue of its conversion in the
body to 2-amino-1-naphthol. On the basis of these findings, a hypothesis covering
the mode ofactionofthe aromatic aminesin general has beenputforward (Clayson,
1953). However, doubts as to the validity of these postulates have persistedduein
part tothefact that in afew cases theinjectionofoilysolutions of 2-naphthylamine
(Hackmann, 1951) or of extracts of the chemical (Case and Pearson, 1952) has
resulted in the appearance of subcutaneous sarcomas. Thus there was the
possibility that the carcinogenic activity of 2-naphthylamine was due to an
impurity present to a small extent in the substance used by Bonser (1943) and to
a greater extent in the crude industrial material used by Hueper (1938).
The following experiments were carried otit to test the local and distant
carcinogenic properties of 2-naphthylamine following its subcutaneous injection
into mice, and to discover whether the chemical, highly purified by gradient
sublimation, as developed by Dr. R. A. M. Case (cf Henson, Somerville,
Farquharson and Goldblatt, 1954), was carcinogenic to dogs.
MATERIALS
2-Naphthylamine purified as described by Bonser (1943) and supplied by
British Drug Houses Ltd., was termed BDH.
2-Naphthylamine purified by the process of gradient sublimation described by
Henson et al. (1954) was stored before use at 0° C. and was termed RCH.
Mongrel dogs were used.
All the organs were examined post mortem and the bladder, liver and kidneys
were examined microscopically. The bladder of one dog (86) was examined by
cystoscope during life.
For experiments 2-4, Swiss type albino mice, approximately 12 weeks of age,
were obtained in one batch from a dealer. Some spontaneous tumours of
lymphoid tissue and one ovarian and one breast tumour occurred in a control
group injected with arachis oil only but no hepatomas were observed among 11
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The CBA mice were from a colony inbred for over 70 generations. Bonser
et al. (1952) reported an incidence of 8-1 per cent of hepatomas in breeding mice
of this strain. During the period of the present investigation one hepatoma was
observed in a female at 123 weeks of age among 5 male and 10 female breeding
mice which survived more than 78 weeks. The mice were approximately 12
weeks of age at the commencement of treatment.
The livers of all the mice, both control and experimental, were examined
microscopically. In all but a very few mice living for 50 weeks or more after
the beginning of treatment there were small collections of inflammatory cells
(polymorphs, lymphocytes and fibroblasts) in the portal tracts. In the livers of
experimental mice in which hepatomas occurred, there was no greater degree of
cellular infiltration of the portal tracts. There was, however, mild proliferation
of the bile ducts in many of the livers and in a few there were small benign
cholangiomatous areas.
Experiment 1
2-Naphthylamine (RCH) was given orally in a gelatine capsule 6 days a week
to 4 female dogs. Initially the dose was 200 mg. but this was increased after 6
months to 600 mg. The maximum cumulative dose of chemical administered to
a dog was 310 g.
Dog 87 (female) died after 141 months oftreatment with no neoplastic changes
in the bladder.
Dog 95 (female) received 2-naphthylamine for 1 year only and was killed 1
years after the beginning of treatment. There were no neoplastic changes in the
bladder epithelium.
Dog 89 (female) died after 2 years of treatment. There were over 40 transi-
tional cell papillomas up to 2 cm. in diameter in the bladder (Fig. 1). Although
some were regarded as histologically malignant none was invasive
Dog 86 (female). On cystoscopic examination ofthe bladder 2 years after the
beginning of treatment epithelial elevations and congestion were seen. Feeding
of the chemical was then stopped. On re-examination ten months later two
papillary tumours were seen, one ofwhich was clinically malignant. This dog was
killed 3 years after treatment had been started. At post mortem examination,
many papillomas were present in the bladder, the picture being comparable with
that in Dog 89. The tumours were of transitional-cell type. One was a frank
carcinoma and was invading the muscle of the bladder wall.
Experiment 2
A 3 per cent solution of 2-naphthylamine (BDH) in arachis oil was allowed to
stand for at least 4 weeks. 0.1 ml. of this solution was injected subcutaneously
into albino mice twice weekly for 50 weeks.
Ten of 16 mice surviving 20 or more weeks of treatment developed
subcutaneous sarcomas near the injection sites (Table I). Four of 5 mice dying
after 80 weeks had hepatomas and in three there were areas of cholangioma
(Table II).
Experiment 3
0.1 ml. of a 3 per cent solution of 2-naphthylamine (BDH) in arachis oil,
prepared immediately before use, was injected subcutaneously into albino miceCARCINOGENIC ACTIVITY OF 2-NAPHTHYLAMINE
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twice weekly for 50 weeks. None of 13 mice which survived 33 weeks or more of
treatment developed sarcomas, but 2 of4 mice living over 77 weeks had hepatomas
(Tables I and II).
Experiment 4
The treatment was similar to that in Experiment 3, except that a freshly
prepared solution of 2-naphthylamine (RCH) was used.
Local sarcomas occurred at 37 and 41 weeks of treatment in 2 of 12 mice
surviving for 37-69 weeks. One cholangioma associated with cirrhosis was
observed at 43 weeks and one small hepatoma at 52 weeks The last mouse in
this group died at 69 weeks, 8 weeks before the first hepatoma was seen in
Experiments 2 or 3.
Experiment 5
0.1 ml. of a 3 per cent solution of 2-naphthylamine hydrochloride (RCH),
freshly prepared in warm water, was injected subcutaneously into CBA mice
twice a week for 6 months and then once a week for a further 4 months.
No sarcomas were observed in any of 10 mice surviving more than 58 weeks.
Hepatomas were seen at 77 and 93 weeks in 2 of 8 mice dying after 70 weeks (Table
II).
Experiment 6
The treatment was the same as in Experiment 5, except that 2-naphthylamine
hydrochloride (BDH) was used.
No sarcomas occurred in any of the 11 mice surviving more than 56 weeks of
treatment. Hepatomas were seen in 4 of 11 mice dying after 82 weeks.
DISCUSSION
The induction of bladder tumours in the two dogs ofExperiment 1 which lived
for two years or more is evidence that 2-naphthylamine purified by the most
stringent means is as potent a bladder carcinogen as the chemical used by Bonser
(1943). A summary of the results of treatment with 2-naphthylamine in all
the dogs investigated in Leeds since 1938 is given in Table III. Every dog
treated for 2 years or longer has developed bladder tumours. Few other tests of
carcinogens have yielded tumours in all the experimental animals. These facts
would support the view that the carcinogen is concentrated in the urine. As yet
there has been no report that tumours occur in other sites in dogs fed with 2-
naphthylamine.
The experiments with mice, designed to test whether 2-naphthylamine is a local
or distant carcinogen, or both, have shown that the incidence of local sarcomas
can be greatly reduced by using freshly prepared solutions in oii, or by avoiding
oily solutions altogether and using aqueous solutions of the hydrochloride. In
EXPLANATION OF PLATE.
FIG. 1.-Dog 89, female, oral 2-naphthylamine RCH for 2 years. Bisected bladder showing
multiple papillomata, ranging in size from pinhead to 2 cm. diameter. Most ofthe tumours
are slightly pendunculated, but the largest one (not seen here) was sessile, with a hard
base. x 1 .5.BRITISH JOURNAL OF CANCEIR.
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TABLE III.-Dogs treated with 2-naphthylamine by mouth
Source
Dog Survival of Bladder
No. Sex. (years). chemrical. tumours. Other observations.
I . M . 1 . BDH . -*
87 . F 1 . RCH . -
2 . F I.l- . BDH . -
95 . F . 1 RCH - . Received chemical for one year only
89 . F . 2 . ,, . +
86 . F 3 . ,, . + . Received chemical for 2 years only
II F . 3 . BDH . *
III . M . 4 .. ,, . +
1 F . 4¼ . . +
3 . M . 4j ,, . +
IV . M . 5 ,, .
5 . F . 5 . ,, . + . Sodium bicarbonate daily
6 . F . 5 . ,, +.... ..
7 . M . 5 . ..... ..
4 . F . 5 .3. +
* Described by Bonser, 1943.
Experiment 2, in which 2-naphthylamine (BDH) in oily solution was injected
after standing for several weeks, an incidence of 63 per cent oflocal sarcomas was
obtained (Table I), but in Experiments 3 and 4 in which freshly prepared oily
solutions of 2-naphthylamine (BDH and RCH) were used, the incidence of these
tumours was reduced to 8 per cent. In Experiments 5 and 6, in which the
aqueous hydrochloride was used, local sarcomas were eliminated altogether. It
is deduced from these results that on standing oily solutions of 2-naphthylamine
develop local carcinogenic properties. A similar change may well take place when
freshly prepared oily solutions are introduced into the subcutaneous tissues, thus
accounting for the small yield of sarcomas in mice which received such solutions.
In assessing the significance ofthe occurrence ofhepatomas, it should be noted
that these arose late, i.e. with one exception after the 70th week. From Experi-
ments 5 and 6 it is apparent that hepatomas can be induced by 2-naphthy]amine
hydrochloride without accompanying sarcomas. The induction time of liver
tumours in all experiments was, with one exception, between 77 and 91 weeks,
but only one sarcoma occurred after 54 weeks. It is thus possible that the causa-
tive agent of the sarcomas in these experiments is different from that which
induced the hepatomas. The hepatoma incidence in mice treated with 2-
naphthylamine was 66 per cent after. 70 weeks or more, and with 2-naphthylamine
hydrochloride 33 per cent. These results are comparable with those reported by
Bonser et al. (1952), within the limits of the small number of effective mice.
SUMMARY
1. Oral administration of very pure 2-naphthylamine induced multiple
tumours of the bladder in 2 dogs surviving 2 years or more of treatment.
2. Local sarcomas were induced in 63 per cent of mice injected subcutaneously
with an oily solution of 2-naphthylamine which had stood for 4 weeks.
3. When freshly prepared oily solutions of 2-naphthylamine were similarly
injected the incidence of local sarcomas was reduced to 8 per cent.
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4. Subcutaneous injection of 2-naphthylamine hydrochloride did not induce
local sarcomas.
5. Although spontaneous hepatomas occurred in control CBA breeding mice
a greater incidence occurred in nmice which received either specially purified or
"partially "purified 2-naphthylamine in theform ofinjections in oil or as aqueous
solutions of the hydrochloride.
6. It is concluded that 2-naphthylamine purified by gradient sublimation
is carcinogenic to the dog and the mouse.
The 2-naphthylamine, purified by gradient sublimation, was a gift from the
Chester Beatty (K. lab) through the kind offices of Professor F. Bergel, to whom
the authors wish to express their thanks.
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